search
Back to results

Comparing Use of Radiographs Versus Patient Empowerment (CURVE) (CURVE)

Primary Purpose

Adolescent Idiopathic Scoliosis

Status
Recruiting
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Patient-empowered follow up
Standard follow-up
Sponsored by
Radboud University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Adolescent Idiopathic Scoliosis focused on measuring Scoliosis, Spine, Quality of Health Care, Cost-Benefit Analysis, Patient Participation, Radiology

Eligibility Criteria

10 Years - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with adolescent idiopathic scoliosis (AIS).
  • Age: 10-18 years old.
  • Patients scheduled for follow up in one of the participating centres.
  • Understanding of the Dutch language.
  • Signed informed consent.
  • Biplanar (Posterior-Anterior [PA] and Lateral) full-spine x-rays within the last 3 months.

Specifically for the pre-treatment group:

  • Girls aged ≤14 years (i.e. 10-14 years) and boys <16 years (i.e. 10-15 years). These patients still have generally 2 years of remaining skeletal growth. Patients above this age with a curve below 25 degrees have a limited risk for progression
  • Girls: pre-menarche up to 6 months post-menarche (to estimate end of growth)
  • A primary coronal curve of 10-25 degree.

Specifically for the post-brace group:

  • Patients aged 12-18 years
  • Within 3 months after termination of brace treatment
  • Minimum of 6 months of brace treatment

Specifically for the post-surgery group:

• Patients aged 12-18 years

Exclusion Criteria:

  • Patients with juvenile or infantile idiopathic scoliosis with the diagnosis of onset under the age of 10.
  • Patients who are undergoing brace treatment. These patients are not included because of the need to monitor brace therapy with radiographs.
  • Patients who have undergone previous spinal surgery and are undergoing revision surgery.
  • Skeletally mature patients.

Sites / Locations

  • Isala
  • Flevo ziekenhuis
  • Rijnstate
  • St Jansdal
  • Zuyderland
  • Maastricht UMC+
  • Viecuri
  • Jeroen Bosch ziekenhuis
  • Sint MaartenskliniekRecruiting
  • AmphiaRecruiting
  • Maxima Medisch Centrum
  • ETZ Elisabeth
  • Noordwestziekenhuis groep
  • OLVGRecruiting
  • Amsterdam UMC
  • Spaarne Gasthuis
  • Dijklander
  • Meander
  • Juliana kinderziekenhuis
  • Albert Schweitzer ziekenhuis
  • Groene Hart ziekenhuis
  • Leiden UMCRecruiting
  • Erasmus MCRecruiting
  • Maasstad ziekenhuis
  • UMC Groningen
  • UMC UtrechtRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Experimental

Arm Label

Standard follow-up

Patient-empowered follow-up

Arm Description

standard care during follow-up

Outcomes

Primary Outcome Measures

The proportion of radiographs that has led to treatment consequences
the proportion will serve as an indication of the sensitivity of the new PE-FU protocol and standard FU protocol. The number of x-rays that has led to treatment will be divided by the total number of x-rays in each subgroup to calculate the primary outcome.

Secondary Outcome Measures

The safety of the standard and the new protocol
The number of false negative radiological findings with treatment consequences not detected by any of the protocols at the end of the study period. This consists of the proportion of patients with delayed detection of progression or post-operative complications (e.g. a pseudo-arthrosis, curve progression, adding on), which requires treatment or increased vigilance.
The specificity, negative predictive value and positive predictive value of the standard and new patient empowered follow up protocol.
The change in readiation exposure
The exposure in the new follow up will be compared to standard care using reference values
Participants perspective: Numeric pain rating scale [NPRS 0-10]
Numeric rating scale for back pain, score range 0-10, 0 no pain at all and 10 wrost pain imaginable.
Participants perspective: condition-specific quality of life [SRS-22r]
Scoliosis Research Society 22 items about function, pain, self image, mental health and statifaction.
Participants perspective: health-related quality of life [EQ5D-5L]
Dutch EQ-5D-5L using the Dutch utility score.
Participants perspective: Scoliosis Appearance questionnaire short version [short SAQ])
Dutch version of the scoliosis appearance questionnaire.
Global perceirved effect [GPE]
the recovery and statisfaction of the participant during and after treatment.
educational status
questions related to absence from school, absence from physical education classes, frequency of missing school exams, necessity to repeat a class, support and alternatives provided by the school, and return to school and sport after surgery.
Self-assessment tool: Scolioscoop
Change in the trunk asymmetry (degrees).
Cost-Benefit analysis: Patient outcome analysis using Quality-Adjusted Life Years (QALY).
Patient outcome analysis is based on EQ5D-5L.
Cost-Benefit analysis: Cost analysis
The costs will be assessed from a societal and a healthcare perspective. From the societal perspective, intervention, other healthcare, unpaid productivity, informal care, and absenteeism costs will be included, whereas only costs accruing to the formal Dutch healthcare sector will be included for the healthcare perspective.

Full Information

First Posted
May 6, 2022
Last Updated
November 1, 2022
Sponsor
Radboud University Medical Center
Collaborators
ZonMw: The Netherlands Organisation for Health Research and Development, Trialbureau Zorgevaluatie Nederland, Nederlandse Orthopaedische Vereniging, Vereniging Scoliose Patiënten, Dutch Adolescent Idiopathic Scoliosis (AIS) Consortium
search

1. Study Identification

Unique Protocol Identification Number
NCT05379127
Brief Title
Comparing Use of Radiographs Versus Patient Empowerment (CURVE)
Acronym
CURVE
Official Title
"The (Cost-)Effectiveness of a Patient Empowered Protocol Without Routine X-rays for Follow-up of Adolescent Idiopathic Scoliosis Patients; A Pragmatic Randomized Trial"
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Recruiting
Study Start Date
July 17, 2022 (Actual)
Primary Completion Date
December 31, 2025 (Anticipated)
Study Completion Date
December 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Radboud University Medical Center
Collaborators
ZonMw: The Netherlands Organisation for Health Research and Development, Trialbureau Zorgevaluatie Nederland, Nederlandse Orthopaedische Vereniging, Vereniging Scoliose Patiënten, Dutch Adolescent Idiopathic Scoliosis (AIS) Consortium

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Objective: To evaluate the (cost-)effectiveness of a new patient-empowered follow up (FU) protocol in patients with Adolescent idiopathic Scoliosis (AIS) that is based on patient-reported outcome measures (PROMs), self-assessment tools and physical examination, which is compared to standard FU care by: 1) Effect evaluation, 2) Economic evaluation, 3) Implementation (process) evaluation. Study design: A multicentre pragmatic randomized trial design with two arms, combined with a patient preference cohort for each arm (partially randomized preference trial [PRPT]). Study population: A total of 812 AIS patients (age 10-18 years) treated by the Dutch AIS Consortium, representing the scoliosis treatment centres in the Netherlands, will be included. Three subgroups of AIS patients are distinguished, which are monitored over two years: Pre-treatment group: adolescents with curve 10-25° (n=132 per arm; total n=264) Post-brace treatment group (n=122 per arm; total n=244) Post-surgery group (n=152 per arm; total n=304) Intervention: The new patient-empowered FU protocol (PE-FU) is based on PROMs, self-assessment tools and clinical assessment including physical examination. The protocol aims to detect curve progression or postoperative complications based on these patient-based and clinical parameters to substitute the need to obtain routine x-rays. X-rays will only be taken when progression or postoperative complications are suspected in the pre- and post-intervention groups based on predefined criteria. The standard FU protocol consists of routine full-spine radiographs and routine clinical evaluations.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Adolescent Idiopathic Scoliosis
Keywords
Scoliosis, Spine, Quality of Health Care, Cost-Benefit Analysis, Patient Participation, Radiology

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A multicentre pragmatic randomized trial design with two arms, combined with a patient preference cohort for each arm (partially randomized preference trial; PRPT). The PRPT consists of three separate randomized controlled trials (RCTs) including patients in the pre-treatment phase, post-brace phase or post-operative phase. Alongside the RCTs prospective preference cohorts are included for each treatment arm (patient empowered follow up [PE-FU] or standard follow up [standard FU]). In the preference cohorts all patients are monitored who are not willing (i.e. who have a preference for either the standard FU or PE-FU) to be randomized to either treatment arm, but who are still willing to participate in the study. By including preference cohorts the generalizability of study results is studied while the internal validity is assured. Half of participants (n=406) allocation: randomized (RCT) Half of participants (n=406) allocation: based on preference (preference cohorts)
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
812 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standard follow-up
Arm Type
Other
Arm Description
standard care during follow-up
Arm Title
Patient-empowered follow-up
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
Patient-empowered follow up
Intervention Description
The patient-empowered follow-up protocol consists of patient-reported outcome measures (PROMs), self-assessment tools and clinical assessment including physical examination. Radiographs will only be taken when progression of the scoliosis (curve progression) or postoperative complications are suspected based on test results and based on the criteria of so called 'sense of alarm'. Note: Sense of alarm ('niet pluis') is based on any deterioration on the above-mentioned PROMs, self-assessment tool, and clinician-based measurement instruments, which is a signal for the treating physician to consider when a radiograph is appropriate. Sense of alarm is described as any other concern by the orthopaedic surgeon, parent or child which warrants a radiograph. For both the Bunnell Scoliometer (clinical assessment tool) and the Scolioscoop (patient self-assessment tool) a threshold of ≥4° is used.
Intervention Type
Other
Intervention Name(s)
Standard follow-up
Intervention Description
Routine radiographs are taken at each follow up visit during standard care (to detect possible curve progression or rule out postoperative complications).
Primary Outcome Measure Information:
Title
The proportion of radiographs that has led to treatment consequences
Description
the proportion will serve as an indication of the sensitivity of the new PE-FU protocol and standard FU protocol. The number of x-rays that has led to treatment will be divided by the total number of x-rays in each subgroup to calculate the primary outcome.
Time Frame
24 months
Secondary Outcome Measure Information:
Title
The safety of the standard and the new protocol
Description
The number of false negative radiological findings with treatment consequences not detected by any of the protocols at the end of the study period. This consists of the proportion of patients with delayed detection of progression or post-operative complications (e.g. a pseudo-arthrosis, curve progression, adding on), which requires treatment or increased vigilance.
Time Frame
for pre-treatment and the post-brace group at 6, 12,18 and 24 months and for the postsurgery group at 3,12 and 24 months
Title
The specificity, negative predictive value and positive predictive value of the standard and new patient empowered follow up protocol.
Time Frame
24 months
Title
The change in readiation exposure
Description
The exposure in the new follow up will be compared to standard care using reference values
Time Frame
24 months
Title
Participants perspective: Numeric pain rating scale [NPRS 0-10]
Description
Numeric rating scale for back pain, score range 0-10, 0 no pain at all and 10 wrost pain imaginable.
Time Frame
24 Months
Title
Participants perspective: condition-specific quality of life [SRS-22r]
Description
Scoliosis Research Society 22 items about function, pain, self image, mental health and statifaction.
Time Frame
24 months
Title
Participants perspective: health-related quality of life [EQ5D-5L]
Description
Dutch EQ-5D-5L using the Dutch utility score.
Time Frame
24 months
Title
Participants perspective: Scoliosis Appearance questionnaire short version [short SAQ])
Description
Dutch version of the scoliosis appearance questionnaire.
Time Frame
24 months
Title
Global perceirved effect [GPE]
Description
the recovery and statisfaction of the participant during and after treatment.
Time Frame
24 months
Title
educational status
Description
questions related to absence from school, absence from physical education classes, frequency of missing school exams, necessity to repeat a class, support and alternatives provided by the school, and return to school and sport after surgery.
Time Frame
24 months
Title
Self-assessment tool: Scolioscoop
Description
Change in the trunk asymmetry (degrees).
Time Frame
or pre-treatment and the post-brace group at 6, 12,18 and 24 months and for the postsurgery group at 3,12 and 24 months
Title
Cost-Benefit analysis: Patient outcome analysis using Quality-Adjusted Life Years (QALY).
Description
Patient outcome analysis is based on EQ5D-5L.
Time Frame
24 months
Title
Cost-Benefit analysis: Cost analysis
Description
The costs will be assessed from a societal and a healthcare perspective. From the societal perspective, intervention, other healthcare, unpaid productivity, informal care, and absenteeism costs will be included, whereas only costs accruing to the formal Dutch healthcare sector will be included for the healthcare perspective.
Time Frame
24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
10 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with adolescent idiopathic scoliosis (AIS). Age: 10-18 years old. Patients scheduled for follow up in one of the participating centres. Understanding of the Dutch language. Signed informed consent. Biplanar (Posterior-Anterior [PA] and Lateral) full-spine x-rays within the last 3 months. Specifically for the pre-treatment group: Girls aged ≤14 years (i.e. 10-14 years) and boys <16 years (i.e. 10-15 years). These patients still have generally 2 years of remaining skeletal growth. Patients above this age with a curve below 25 degrees have a limited risk for progression Girls: pre-menarche up to 6 months post-menarche (to estimate end of growth) A primary coronal curve of 10-25 degree. Specifically for the post-brace group: Patients aged 12-18 years Within 3 months after termination of brace treatment Minimum of 6 months of brace treatment Specifically for the post-surgery group: • Patients aged 12-18 years Exclusion Criteria: Patients with juvenile or infantile idiopathic scoliosis with the diagnosis of onset under the age of 10. Patients who are undergoing brace treatment. These patients are not included because of the need to monitor brace therapy with radiographs. Patients who have undergone previous spinal surgery and are undergoing revision surgery. Skeletally mature patients.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Miranda L van Hooff, PhD
Phone
+31 24 361 3366
Email
Miranda.vanHooff@radboudumc.nl
First Name & Middle Initial & Last Name or Official Title & Degree
Jurre Baetsen, MSc
Phone
+31 6 55742308
Email
Jurre.Baetsen@radboudumc.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Miranda L van Hooff, PhD
Organizational Affiliation
Radboud University Medical Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Marinus de Kleuver, MD, PhD
Organizational Affiliation
Radboud University Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Isala
City
Zwolle
State/Province
Drenthe
ZIP/Postal Code
8025AB
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
A Mostert, Dr.
Facility Name
Flevo ziekenhuis
City
Almere
State/Province
Flevoland
ZIP/Postal Code
1315RA
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
B Blom, drs.
Facility Name
Rijnstate
City
Arnhem
State/Province
Gelderland
ZIP/Postal Code
6815 AD
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
J van Susante
Facility Name
St Jansdal
City
Harderwijk
State/Province
Gelderland
ZIP/Postal Code
3844 DG
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
P Lammers, drs.
Facility Name
Zuyderland
City
Heerlen
State/Province
Limburg
ZIP/Postal Code
6419PC
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
I Curfs, drs.
Facility Name
Maastricht UMC+
City
Maastricht
State/Province
Limburg
ZIP/Postal Code
6229HX
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
P Willems, prof. dr.
Facility Name
Viecuri
City
Venlo
State/Province
Limburg
ZIP/Postal Code
5912
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
M Hulsbosch, drs.
Facility Name
Jeroen Bosch ziekenhuis
City
's-Hertogenbosch
State/Province
Noord-Brabant
ZIP/Postal Code
5223 GZ
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
B van der Zwaard, dr.
Facility Name
Sint Maartenskliniek
City
Boxmeer
State/Province
Noord-Brabant
ZIP/Postal Code
5835 DV
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
P Bisseling, Dr.
Facility Name
Amphia
City
Breda
State/Province
Noord-Brabant
ZIP/Postal Code
4818CK
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
E Hoebink, dr.
Facility Name
Maxima Medisch Centrum
City
Eindhoven
State/Province
Noord-Brabant
ZIP/Postal Code
5631 BM
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
A Besselaar, drs.
Facility Name
ETZ Elisabeth
City
Tilburg
State/Province
Noord-Brabant
ZIP/Postal Code
5022GC
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
R Geuze, dr.
Facility Name
Noordwestziekenhuis groep
City
Alkmaar
State/Province
Noord-Holland
ZIP/Postal Code
1815JD
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
H Graat
Facility Name
OLVG
City
Amsterdam
State/Province
Noord-Holland
ZIP/Postal Code
1091AC
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
D Kempen, dr.
Facility Name
Amsterdam UMC
City
Amsterdam
State/Province
Noord-Holland
ZIP/Postal Code
1105AZ
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Name
Spaarne Gasthuis
City
Haarlem
State/Province
Noord-Holland
ZIP/Postal Code
2035 RC
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
R Hoogendoorn, dr.
Facility Name
Dijklander
City
Hoorn
State/Province
Noord-Holland
ZIP/Postal Code
1624NP
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
E Kraaneveld, drs.
Facility Name
Meander
City
Amersfoort
State/Province
Utrecht
ZIP/Postal Code
3813TZ
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
T.D. Berendes, dr.
Facility Name
Juliana kinderziekenhuis
City
Den Haag
State/Province
Zuid-Holland
ZIP/Postal Code
2545 AA
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
J van Linge, drs.
Facility Name
Albert Schweitzer ziekenhuis
City
Dordrecht
State/Province
Zuid-Holland
ZIP/Postal Code
3318 AT
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
W.J. Marijnissen, dr.
Facility Name
Groene Hart ziekenhuis
City
Gouda
State/Province
Zuid-Holland
ZIP/Postal Code
2803HH
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
P Haen, drs.
Facility Name
Leiden UMC
City
Leiden
State/Province
Zuid-holland
ZIP/Postal Code
2333ZA
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
P.B. de Witte, dr.
Facility Name
Erasmus MC
City
Rotterdam
State/Province
Zuid-Holland
ZIP/Postal Code
3015GD
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
J Rutgens, dr.
First Name & Middle Initial & Last Name & Degree
H van West, drs.
Facility Name
Maasstad ziekenhuis
City
Rotterdam
State/Province
Zuid-Holland
ZIP/Postal Code
3079 DZ
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
W Bakker, drs.
Facility Name
UMC Groningen
City
Groningen
ZIP/Postal Code
9713
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
C Faber, dr.
Facility Name
UMC Utrecht
City
Utrecht
ZIP/Postal Code
3584 CX
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
T Schlösser, dr.

12. IPD Sharing Statement

Learn more about this trial

Comparing Use of Radiographs Versus Patient Empowerment (CURVE)

We'll reach out to this number within 24 hrs